An MDMA analogue which could end up in direct competition with Emyria's own ones. Very strange.
All to generate some professional fees. Emeryia has changed so much from a promising biotech to a clinical service provider.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $15.89M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.8¢ | 2.6¢ | $32.17K | 1.164M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 474329 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 702242 | 4 |
View Market Depth
| Last trade - 16.10pm 02/07/2025 (20 minute delay) ? |
| EMD (ASX) Chart |